Listeria monocytogenes has recently been exploited as a vector for tar
geting antigens to the immune system. In the past year it has been sho
wn to be particularly effective as a tumor antigen vector. Here we set
its potency as a cancer vaccine in the context of the type of immunit
y induced by this facultative intracellular bacterium.